138 related articles for article (PubMed ID: 9466675)
1. The anti-mitogenic activity of 17beta-estradiol in coronary smooth muscle cells correlates with protein binding to its responsive element.
Ramos KS; Sadhu DN; Meininger CJ; Chilian WM
In Vitro Cell Dev Biol Anim; 1997; 33(10):738-41. PubMed ID: 9466675
[No Abstract] [Full Text] [Related]
2. Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained from mature female versus male animals.
Moraghan T; Antoniucci DM; Grenert JP; Sieck GC; Johnson C; Miller VM; Fitzpatrick LA
Endocrinology; 1996 Nov; 137(11):5174-7. PubMed ID: 8895395
[TBL] [Abstract][Full Text] [Related]
3. Estrogen increases Ca2+ efflux from female porcine coronary arterial smooth muscle.
Prakash YS; Togaibayeva AA; Kannan MS; Miller VM; Fitzpatrick LA; Sieck GC
Am J Physiol; 1999 Mar; 276(3):H926-34. PubMed ID: 10070076
[TBL] [Abstract][Full Text] [Related]
4. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells.
Bhalla RC; Toth KF; Bhatty RA; Thompson LP; Sharma RV
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1996-2003. PubMed ID: 9139988
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of estradiol to rat coronary artery smooth muscle cells.
Bei M; Lavigne MC; Foegh ML; Ramwell PW; Clarke R
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):83-8. PubMed ID: 8809189
[TBL] [Abstract][Full Text] [Related]
6. Gender-related differences in proliferative responses of vascular smooth muscle cells to endothelin-1.
Antoniucci D; Miller VM; Sieck GC; Fitzpatrick LA
Endothelium; 2001; 8(2):137-45. PubMed ID: 11572475
[TBL] [Abstract][Full Text] [Related]
7. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery.
Vargas R; Wroblewska B; Rego A; Hatch J; Ramwell PW
Br J Pharmacol; 1993 Jul; 109(3):612-7. PubMed ID: 8358561
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2004 Aug; 89(8):3922-31. PubMed ID: 15292328
[TBL] [Abstract][Full Text] [Related]
9. Gender-related differences in the development of atherosclerosis: studies at the cellular level.
Fitzpatrick LA
Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):267-9. PubMed ID: 8934620
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of atherosclerosis.
Fitzpatrick LA; Ruan M; Anderson J; Moraghan T; Miller V
Lupus; 1999; 8(5):397-401. PubMed ID: 10455521
[TBL] [Abstract][Full Text] [Related]
11. 17Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism.
Yoon BK; Oh WJ; Kessel B; Roh CR; Choi D; Lee JH; Kim DK
Menopause; 2001; 8(1):58-64. PubMed ID: 11201517
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in the effect of genistein on vascular smooth muscle cells: a possible cardioprotective effect?
Vincent A; Ruan M; Fitzpatrick LA
J Gend Specif Med; 2001; 4(1):28-34. PubMed ID: 11324237
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase.
Geraldes P; Sirois MG; Bernatchez PN; Tanguay JF
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1585-90. PubMed ID: 12377734
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor.
Keyes LE; Moore LG; Walchak SJ; Dempsey EC
J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771
[TBL] [Abstract][Full Text] [Related]
15. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels.
Lou H; Zhao Y; Delafontaine P; Kodama T; Katz N; Ramwell PW; Foegh ML
Circulation; 1997 Aug; 96(3):927-33. PubMed ID: 9264503
[TBL] [Abstract][Full Text] [Related]
16. Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells.
Seeger H; Wallwiener D; Mueck AO
Menopause; 2001; 8(1):5-9. PubMed ID: 11201515
[TBL] [Abstract][Full Text] [Related]
17. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation.
Lavigne MC; Ramwell PW; Clarke R
Steroids; 1999 Jul; 64(7):472-80. PubMed ID: 10443903
[TBL] [Abstract][Full Text] [Related]
19. Role of putative membrane receptors in the effects of estradiol on human vascular cell growth.
Somjen D; Kohen F; Gayer B; Sharon O; Baz M; Limor R; Kulik T; Knoll E; Stern N
Am J Hypertens; 2004 May; 17(5 Pt 1):462-9. PubMed ID: 15110908
[TBL] [Abstract][Full Text] [Related]
20. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Imthurn B; Keller PJ
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):964-72. PubMed ID: 10764660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
